Compare · VIVO vs XEL
VIVO vs XEL
Side-by-side comparison of VivoPower PLC (VIVO) and Xcel Energy Inc. (XEL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both VIVO and XEL operate in Power Generation (Utilities), so they compete in similar markets.
- XEL is the larger of the two at $49.11B, about 470.4x VIVO ($104.4M).
- Over the past year, VIVO is down 41.7% and XEL is up 9.9% - XEL leads by 51.6 points.
- VIVO has been more active in the news (14 items in the past 4 weeks vs 6 for XEL).
- XEL has more recent analyst coverage (25 ratings vs 3 for VIVO).
VivoPower PLC
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare and PediaStat brands; and urea breath testing for H. pylori under the BreathID brand. This segment also offers gastrointestinal assays, including tests for C. difficile, H. pylori, and certain foodborne pathogens; respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry assays for testing elevated levels of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. The company has a strategic collaboration with DiaSorin Inc. to sell H. pylori tests. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
Xcel Energy Inc.
Xcel Energy Inc., through its subsidiaries, generates, purchases, transmits, distributes, and sells electricity. It operates through Regulated Electric Utility, Regulated Natural Gas Utility, and All Other segments. The company generates electricity through coal, nuclear, natural gas, hydroelectric, solar, biomass, oil, wood/refuse, and wind energy sources. It also purchases, transports, distributes, and sells natural gas to retail customers, as well as transports customer-owned natural gas. In addition, the company develops and leases natural gas pipelines, and storage and compression facilities; and invests in rental housing projects, as well as procures equipment for the construction of renewable generation facilities. It serves residential, commercial, and industrial customers in the portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. The company sells electricity to approximately 3.7 million customers; and natural gas to approximately 2.1 million customers. Xcel Energy Inc. was incorporated in 1909 and is headquartered in Minneapolis, Minnesota.
Latest VIVO
- SEC Form 6-K filed by VivoPower PLC
- VivoPower Appoints Group Finance Director
- SEC Form 6-K filed by VivoPower PLC
- Noble Capital Markets Initiates Equity Research Coverage on VivoPower
- Amendment: SEC Form 6-K/A filed by VivoPower PLC
- Amendment: SEC Form 6-K/A filed by VivoPower PLC
- SEC Form 6-K filed by VivoPower PLC
- SEC Form 6-K filed by VivoPower PLC
- VivoPower Targets Up To USD$4 million Incremental Annualized EBITDA from Battery Energy Storage Integration at Norway Data Center
- VivoPower Reinforces Focus on AI Data Center Business and Provides Update on Non-Core Businesses
Latest XEL
- Xcel Energy 2026 Second Quarter Earnings Conference Call
- Director Burkhart Megan D was granted 584 shares, increasing direct ownership by 3% to 23,841 units (SEC Form 4)
- Director Kampling Patricia L was granted 608 shares, increasing direct ownership by 2% to 25,158 units (SEC Form 4)
- Director Casey Lynn was granted 493 shares, increasing direct ownership by 1% to 43,616 units (SEC Form 4)
- Director Pardee Charles G was granted 541 shares, increasing direct ownership by 2% to 33,852 units (SEC Form 4)
- Director Welsh Timothy A was granted 468 shares, increasing direct ownership by 3% to 17,487 units (SEC Form 4)
- SEC Form 11-K filed by Xcel Energy Inc.
- SEC Form 11-K filed by Xcel Energy Inc.
- SEC Form 11-K filed by Xcel Energy Inc.
- Xcel Energy Powering Communities, Economies as Energy Landscape Evolves